- Home
- JSPRW
JSPRW
Japer Therapeutics Inc.
as 07-26-2024 4:00pm EST
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
| Founded: | N/A | Country: | United States |
| Employees: | 45 | City: | REDWOOD CITY |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Japer Therapeutics Inc. News
JSPRW Breaking Stock News: Dive into JSPRW Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire
a month ago
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
GlobeNewswire
a month ago
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
Simply Wall St.
2 months ago
Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
GlobeNewswire
2 months ago
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
GlobeNewswire
2 months ago
Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
2 months ago
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
GlobeNewswire
2 months ago
Jasper Therapeutics Announces Briquilimab Development Program in Asthma
Compare JSPRW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JSPRW Japer Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.